A carregar...
MicroRNA-218 enhances gastric cancer cell cisplatin sensitivity by targeting survivin
Gastric cancer (GC) is one of the most prevalent types of cancer worldwide. Cisplatin based chemotherapy is the primary strategy implemented for the treatment of G; however, chemoresistance is a major problem. Previous studies have indicated that microRNAs (miRs) are associated with chemoresistance...
Na minha lista:
| Publicado no: | Exp Ther Med |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
D.A. Spandidos
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6257577/ https://ncbi.nlm.nih.gov/pubmed/30542435 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2018.6802 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|